Skip to main content
Webinars
New Strategies in Colorectal Management during COVID-19 Pandemic
Perspectives from the Frontline of Fighting COVID-19
Status of MIS in General Surgery in the COVID-19 Pandemic | Part 1
Status of MIS in General Surgery in the COVID-19 Pandemic | Part 2
Leadership during COVID-19 | Part 1
Leadership during COVID-19 | Part 2
Managing COVID-19 patients presenting with emergencies
Global Perspectives: Thoracic Surgery on the Frontline of COVID-19
The New Normal in Elective surgery
Ortho & Spine Surgery in the Time of COVID-19
Thoracic Surgery on the Frontline of COVID-19
Shaping the Next Normal in Elective Surgery
Collaborating to Shape the Next Normal in Elective Surgery
Preparing for surgery after COVID-19: Role of energy sources
Challenges and Solutions during Covid-19 Phase 2
Free Courses
Video Tutorials
Diagnosis
PPE
Treatment
Ventilators
Podcasts
Guidelines
Q&A
Innovation Showroom
Resilience!
More Assets
Survival Calculator
Forums
Treatment and management
Is there any evidence of the possibility of outpatient use of direct anticoagulants such as Rivaroxaban or Dabigratan?
Created by
Dr. MartÃnez
, 1 May, 2020
